IP Library › Assignment 022928/0057
Patent Assignment
Reel/Frame 022928/0057

Change of Name

Recorded: 2009-07-08 Pages: 3
Assignor
SHIRE BIOCHEM INC.
Executed: 2007-09-18
Assignee
SHIRE CANADA INC.
2250 ALFRED-NOBEL BLVD, SUITE 500, SAINT-LAURENT, QUEBEC, H4S 2C9, CANADA
Covered Properties (2)
Pharmaceutical Formulation Comprising Lanthanum Compounds
Patent: 7,465,465 →
Application: 10/926,330 →
Publication: US 2005/0079135
Pharmaceutical Formulation Comprising Lanthanum Compounds
Application: 12/237,381 →
Publication: US 2009/0017133
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 21, 2004
From: HASLAM, ROBERT PAUL; TRESPIDI, LAURA ANNA; FERDINANDO, JOSEPHINE CHRISTINE
To: SHIRE BIOCHEM INC.
Reel/Frame 016092/0839 →
Corrective Assignment to Correct the to Correct the Assignees Address Previously Recorded on Reel 016092 Frame 0839. Assignor(S) Hereby Confirms the the Entire Right, Title and Interest in and to Said Invention and Any Renewals, Reissues, Reexamination and Extensions Thereof.. Feb 18, 2009
From: HASLAM, ROBERT PAUL; TRESPIDI, LAURA ANNA; FERDINANDO, JOSEPHINE CHRISTINE
To: SHIRE BIOCHEM INC.
Reel/Frame 022276/0362 →
Assignment of Assignor's Interest Apr 19, 2021
From: TAKEDA CANADA INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055963/0992 →